日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Distinct Clinical and Biological Features of Diffusely Metastatic Versus Bulky Localized Lung Cancer: Real-World Outcomes from a University Cancer Center in Germany

弥漫性转移性肺癌与局限性大肿块肺癌的临床和生物学特征差异：来自德国一家大学癌症中心的真实世界研究结果

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17233728
Resuli, Blerina; Walter, Julia; Kauffmann-Guerrero, Diego; Behr, Jürgen; Arnold, Paola; Götschke, Jeremias; Leuschner, Gabriela; Kovács, Julia; Eze, Chukwuka; Schneider, Christian; Tufman, Amanda
肺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Regression models for the prediction of the influence of magnesium ions on primary endothelial cell (HUVEC) proliferation and migration

预测镁离子对原代内皮细胞（HUVEC）增殖和迁移影响的回归模型

期刊:Computational and Structural Biotechnology Journal
影响因子:4.1
doi:10.1016/j.csbj.2025.06.023
Helmholz, Heike; Resuli, Redon; Tacke, Marius; Nourisa, Jalil; Tomforde, Sven; Aydin, Roland; Willumeit-Römer, Regine; Zeller-Plumhoff, Berit
细胞生物学
内皮细胞
发表日期：2025
文献求助 收藏

Changes in prescribing patterns and access to immune checkpoint inhibitors in german lung cancer patients - a claims data analysis

德国肺癌患者免疫检查点抑制剂处方模式及获取途径的变化——一项基于理赔数据分析的研究

期刊:BMC Public Health
影响因子:3.6
doi:10.1186/s12889-025-23846-2
Walter, Julia; Resuli, Blerina; Sellmer, Laura; Kauffmann-Guerrero, Diego; Bolt, Toki; Eze, Chukwuka; Behr, Jürgen; Tufman, Amanda
肺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Will INSPIRE crown iruplinalkib as a new standard choice in first-line advanced ALK-positive non-small cell lung cancer?

INSPIRE 研究能否确立 iruplinalkib 作为一线治疗晚期 ALK 阳性非小细胞肺癌的新标准选择？

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-24-655
Resuli, Blerina; Kauffmann-Guerrero, Diego
肺癌
肿瘤
肿瘤免疫
ALK
细胞生物学
发表日期：2025
文献求助 收藏

Treatment Strategies for First-Line PD-L1-Unselected Advanced NSCLC: A Comparative Review of Immunotherapy-Based Regimens by PD-L1 Expression and Clinical Indication

一线PD-L1非选择性晚期非小细胞肺癌治疗策略：基于PD-L1表达和临床适应症的免疫治疗方案比较综述

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics15151937
Resuli, Blerina; Kauffmann-Guerrero, Diego; Arredondo Lasso, Maria Nieves; Behr, Jürgen; Tufman, Amanda
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Safety and efficacy of the combination of selpercatinib with osimertinib in NSCLC: a case report and review of the literature

塞帕替尼联合奥希替尼治疗非小细胞肺癌的安全性和有效性：病例报告及文献综述

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1580322
Resuli, Blerina; Galarza, Heidi; Kauffmann-Guerrero, Diego; Oversohl, Julian; Behr, Jürgen; Tufman, Amanda
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Elevated FDG uptake in non-tumorous lung regions does not predict immune checkpoint inhibitor-related pneumonitis in lung cancer patients

非肿瘤性肺区FDG摄取升高并不能预测肺癌患者免疫检查点抑制剂相关性肺炎的发生

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1563030
Völter, Friederike; Wehlte, Lukas; Resuli, Blerina; Walter, Julia; Daisenberger, Lea; Ingenerf, Maria; Heimer, Maurice; Brendel, Matthias; Sheikh, Gabriel T; Unterrainer, Lena M; Kauffmann-Guerrero, Diego; Pfluger, Thomas; Heinzerling, Lucie; Tufman, Amanda
肺炎
肺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Toxicity Profile and Efficacy of Docetaxel Following Paclitaxel- or Pemetrexed-Platinum Chemotherapy Alone or in Combination With Immune Checkpoint Inhibitors in NSCLC Patients: A Single Institution Retrospective Analysis

多西他赛在非小细胞肺癌患者中单用或联合免疫检查点抑制剂治疗后，其毒性特征和疗效：一项单中心回顾性分析

期刊:Cancer Control
影响因子:2.6
doi:10.1177/10732748251328618
Resuli, Blerina; Walter, Julia; Kauffmann-Guerrero, Diego; Mertsch, Pontus; Arredondo Lasso, Maria; Arnold, Paola; Schneider, Christian; Behr, Jürgen; Tufman, Amanda
Checkpoint
肺癌
肿瘤
肿瘤免疫
细胞生物学
毒理研究
免疫/内分泌
发表日期：2025
文献求助 收藏

Beyond Traditional Risk Factors: Inflammation, Asymmetric Dimethylarginine, and N-Terminal pro-B-Type Natriuretic Peptide Predict Cardiovascular Risk in Chronic Kidney Disease

超越传统风险因素：炎症、不对称二甲基精氨酸和N末端B型利钠肽前体可预测慢性肾脏病患者的心血管风险

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.97654
Hoxha, Eneida; Collaku, Ledio; Kuka, Somida; Seferi, Saimir; Pojani, Pandush; Habilaj, Xhesika; Kambo, Matilda; Zaimi Petrela, Elizana; Bulo, Anyla; Resuli, Margarita
炎症/感染
Immunology/Inflammation
炎症
发表日期：2025
文献求助 收藏

Safety of brigatinib following alectinib-induced-pneumonitis: Case report

阿来替尼诱发肺炎后使用布加替尼的安全性：病例报告

期刊:Respiratory Medicine Case Reports
影响因子:0.7
doi:10.1016/j.rmcr.2024.102160
Resuli, Blerina; Galarza, Heidi; Elsner, Laura; Kauffmann-Guerrero, Diego; Behr, Jürgen; Tufman, Amanda
肺炎
发表日期：2025
文献求助 收藏